Form 4 Filing: Nussbaum Ran Acquires (Grant) shares of $LBRX

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

LB PHARMACEUTICALS INC

Ticker: $LBRX

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-06-03

Shares: 10,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Nussbaum Ran, holds the title of Director at LB PHARMACEUTICALS INC.

On 2026-06-03, the insider transacted 10,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Nussbaum Ran (Director) was granted $0 of $LBRX

Post-Transaction Position: 10,000 shares

SEC Accession No: 0001609805-26-000003 (CIK: 1609805)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$LBRX Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$LBRX News Coverage